Beyond Air, Inc.

Healthcare · Medical Devices · United States

Last price 2.31 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.27M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM). In addition, the company develops ultra-h...